PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 67: Articles 33001-33500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Oral contraceptives. [Les contraceptifs oraux.]
  2. Oral contraceptives: a guide for programs and clinics.
  3. Oral contraceptives: a memorandum to the DHSS.
  4. Oral contraceptives: a review of the literature.
  5. Oral contraceptives: a risk factor for myocardial infarction.
  6. Oral contraceptives: effects on plasma insulin response to glucose and on the response to insulin and 2-deoxyglucose uptake by peripheral tissue (38819)
  7. Oral contraceptives: relation to mammary cancer, benign breast lesions, and cervical cancer.
  8. Oral contraceptives: researchers doubt Vitamin A harms babies.
  9. Oral hormonal contraception with Deposiston. [Orale hormonale Kontrazeption mit Deposiston.]
  10. Oral steroid contraceptive for men.
  11. Organization and management of the division of population control and family planning.
  12. Organizational communication and coordination in family planning programs.
  13. Organizational communication and coordination in family planning programs.
  14. Organizational communication and coordination in family planning programs.
  15. Organizing for government intervention in family planning.
  16. The origins of the birth control movement in England in the early nineteenth century.
  17. Other Anglophone countries. (Family planning programs)
  18. Other Middle Eastern and North African countries. (Family planning programs)
  19. Our resources for contraceptive advice and legal abortions. [Vara resurser ror p-radgivning och de legala aborterna.]
  20. Outline curriculum in family planning nursing for state certified midwives or state registered nurses: course number 900.
  21. Overview (of measuring the effect family planning programs on fertility)
  22. Overview 1973-1974: contraceptive services, family planning programmes, Western Hemisphere Region.
  23. Pakistan. (Family planning programs)
  24. Panama. (Family planning programs)
  25. Pancreatitis, multiple infarcts and oral contraception.
  26. Panel presentation: How can we involve men in family planning education and outreach programs.
  27. Panel presentation: How can we involve men in family planning education and outreach programs?
  28. Panel presentation: How can we involve men in family planning education and outreach programs?
  29. Parental consent requirements and privacy right of minors: the contraceptive controversy.
  30. Parental consent requirements and privacy rights of minors: The contraceptive controversy.
  31. Parents and family planning services. (Abstract only)
  32. The pathology of birth control.
  33. Paths to the adoption of family planning: a time-lagged correlation analysis of the Dacca family planning experiment.
  34. Patient evaluation of the nurse practitioner in family planning.
  35. Patterns of contraceptive failures: the role of motivation re-examined.
  36. Pediatric and nutritional needs of an MCH-based family planning program.
  37. The pediatrician and family planning. [El pediatra y la planificacion familiar.]
  38. Pelvic inflammatory disease in contraceptive acceptors disclosed at transvaginal tubal sterilization.
  39. Perceived contribution of children to marriage and its effects on family planning behavior.
  40. Perforation of the uterus by the Copper-T and Copper-7 intrauterine contraceptive devices.
  41. Performance differentials between family planning acceptors in Mojokerto Regency, East Java, Indonesia.
  42. The performance of Mohtamyae in family planning.
  43. Personality patterns of couples practicing the temperature-rhythm method of birth control.
  44. Perturbations of carbohydrate metabolism provoked by contraceptive steroids. [Perturbations du metabolism glucidique provoquees par les steroides contraceptifs.]
  45. Pharmacists' attitudes toward family planning in Bolivia. [Actitudes de farmaceuticos hacia la planificacion familiar en Bolivia.]
  46. Pharmacological studies of a contraceptive drug Anordrin.
  47. Pharmacological studies of a contraceptive drug Anordrin.
  48. Philippines 08 and 12 mobile INC (Iglesia Ni Cristo) family planning clinics.
  49. Photodermatoses induced by oral contraceptives.
  50. The pill dropouts: the "cafeteria" approach to contraception.
  51. Pill or topical contraception? [Pillola o contraccezione locale?]
  52. A pilot study of three oral contraceptives in Seattle.
  53. Planning a family planning education program.
  54. Planning and target setting for family planning programmes.
  55. Planning communication for family planning. Module text.
  56. Planning communication for family planning. Module workbook.
  57. Planning communication for family planning. Module manager's guide.
  58. Planning for the distribution of contraceptive products through the private sector in Ecuador.
  59. Planning for the distribution of contraceptives in Thailand.
  60. Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive therapy. [Concentrations plasmatiques de LH et des steroides sexuels pendant le cycle menstruel normal et sous therapeutique contraceptive.]
  61. Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension.
  62. Plasma levels of progesterone and oestrogens in women treated with an or al contraceptive of low oestrogen content (Ovostat 1375)
  63. Pleated membrane intrauterine contraceptive device. (Patent)
  64. The politics of population in Communist China: a case study of birth control policy, 1949-1965.
  65. Polycystic ovarian disease and oral contraception. (Letter to the editor)
  66. Population and family planning classification.
  67. Population and family planning education in universities.
  68. Population and family planning in charts, Taiwan area, Republic of China, 6th ed.
  69. Population control in Australia today: contraception, sterilization and abortion.
  70. Population growth and health and family planning.
  71. Population increase and family planning in Guatemala.
  72. Population planning: optimum use of contraceptive methods.
  73. Population policy and family planning programs in the Taiwan area, Republic of China.
  74. The population problem in Indonesia: controlling its growth through family planning and community health care development and an additional pastoral clarification.
  75. The population situation in the region and the family planning and population programme.
  76. Population/Family planning project: A.I.D. field evaluation July 1975: final report.
  77. Porphyria variegata provoked by contraceptive pill.
  78. Possibility of inducing psychosomatic sterility by hypnosis for contraceptive purposes. [La possibilita di indurre l'infertilita psicosomatica mediante ipnosi ai fini della contraccezione.]
  79. Possible influence of hormonal contraception on the X chromatin frequency.
  80. A possible new hazard of the intrauterine contraceptive device.
  81. Possible risk of cancer in situ of the cervix from medroxyprogesterone acetate injectable and other systemic steroidal contraceptives.
  82. Post partum programme in family planning.
  83. Post-coital contraceptive and uterotrophic effects of luteinizing hormone releasing hormone.
  84. Postcoital contraception: current use and future prospects. [La contraception post-coitale: point actuel et perspectives.]
  85. Postoperative deep vein thrombosis in patients on oral contraceptives. (Abstract only)
  86. Postpartum and postabortal insertion of intrauterine contraceptive devices.
  87. Postpartum contraception.
  88. Postpartum-family planning education and acceptance of contraception.
  89. Potentiation of hypothalamic pressor responses in awake rats pretreated with contraceptive steroids.
  90. A practical view of family planning in the industrial set-up.
  91. Practice of birth control.
  92. Practice of family planning methods in Calcutta.
  93. Predicting contraceptive use in postabortion patients.
  94. Pregnancies during oral contraception in patients taking barbiturates. [Grossesses sous contraceptifs oraux chez les patientes recevant des barbituriques.]
  95. Pregnancy and progeny after long-term contraceptive treatment with low-dose progestogens.
  96. Pregnancy in the presence of an intrauterine contraceptive device and amniotic fluid embolism: a possible association.
  97. Pregnancy with an intrauterine contraceptive device.
  98. A preliminary report on a study of vasectomy cases at the Taipei City Family Planning Promotion Center.
  99. Preliminary trials with an oral contraceptive in men. [Premiers essais d'une contraception chimique par voie orale chez l'homme.]
  100. Premarital contraceptive usage: a study and some theoretical explorations.
  101. Prenatal exposure to oral contraceptives and transposition of the great vessels in man.
  102. The preparation Angravid in oral contraception - clinical remarks. [Preparat Angravid w antykoncepcji doustnej - uwagi kliniczne.]
  103. Preparation of tritiated- and carbon-14-labelled contraceptive steroids.
  104. The prescribing and dispensing of oral contraceptives in family planning association clinics.
  105. Present and future availability of starting materials for the production of contraceptive steroids.
  106. The present situation and possibilities of contraception in Hungary. [A fogamzasgatlas jelenlegi helyzete es lehetosegei magyarorszagon.]
  107. Present state of male contraception.
  108. Present technical and psychological aspects of male contraception. [Aspects techniques et psychologiques actuels de la contraception masculine.]
  109. Press statement on oral contraceptives.
  110. Pressor effects of contraceptive steroids in normotensive and renal hypertensive rats. (Abstract only)
  111. Prevalence of gonorrhea among women using various methods of contraception.
  112. Prevention of hematologic complications due to contraceptives. [Prevention des complications hematologiques de la contraception.]
  113. The problem of postcoital contraception using oral progestins. [Il problema della contraccezione post-coitum mediante progestativi orali.]
  114. Problems and needs in population/family planning information, education, and communication: an analysis of Asian programs.
  115. Problems arising in the introduction of IUDs in family planning programs.
  116. Problems facing programme implementation in family planning.
  117. The problems found and lessons learnt from the study [of Mohtamyae and family planning]
  118. Problems of Family Planning in Andhra Pradesh.
  119. Problems of management research in family planning.
  120. Problems of oral contraceptives given during pregnancy - reply. (Letter)
  121. Problems of oral contraceptives given during pregnancy.
  122. Problems of oral contraceptives given during pregnancy. (Letter)
  123. Problems of teenage mothers, their infants, and influence of family planning (Abstract only)
  124. Procedure manual for mother/infant protection and family planning.
  125. Proctological effects of hormonal contraceptives. [Incidences proctologiques de la contraception hormonale.]
  126. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
  127. The profile of family planning defaulters in a Barbadian General Practice.
  128. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
  129. Programa de Planificacion Familiar de la SSA: continuidad de las aceptantes en los servicios y en la anticoncepcion. (Family planning program of the SSA: Continued participation and the use of services and of contraceptive methods)
  130. Progress and performance (in India's Family Planning Program.)
  131. Progress and performance. (Family planning in India)
  132. Progress in family planning programs.
  133. Progress in Family Planning: Taiwan Area, January--June, 1975.
  134. Progress in the acceptance of the family planning methods in India.
  135. Progress of birth control in Canada.
  136. Progress of family planning.
  137. Progress report: hepatic adenomas and oral contraceptives.
  138. Progress towards a male oral contraceptive.
  139. Prompt regression of cystic vaginal adenosis following cessation of oral contraceptive therapy.
  140. Pronatalism and child labor: Chadian attitudes to birth control and family size.
  141. (Proposal on breast feeding and oral contraceptives.)
  142. A proposed conceptual framework for analyzing needs for supervisory training in family planning programs.
  143. Proposed Title 20 rules could jeopardize delivery of family planning services.
  144. Prospects for conception and contraception.
  145. Protein metabolism in women ingesting Stediril-Wyeth preparation as a contraceptive. [Gospodarka bialkowa u kobiet przyjmujacych preparat Stediril-Wyeth w celach antykoncepcyjnych.]
  146. The provision of family planning services in occupational settings: A review and analysis; June 1975.
  147. Provisional Data from the National Reporting System for Family Planning Services, January 1974-December 1974: United States, states, and territories.
  148. Provisional data from the National reporting system for family planning services, July 1975-September 1975.
  149. Provisional data from the National Reporting System for Family Planning Services. January 1975-March 1975.
  150. Provisional data from the National Reporting System for Family Planning Services: January 1974-December 1974: national level.
  151. Provisional data from the National Reporting System for Family Planning Services: October 1974 - December 1974.
  152. A psychiatrist volunteers at a planned parenthood clinic.
  153. Psycho-social aspects of management of family planning programme.
  154. Psycho-sociological conditions for birth control: a medico-sociological contribution concerning attitudes toward contraception. [Psycosoziale Bedingungen der Schwangerschaftsverhuetung -- ein Medizin-Soziologischer Beitrag zum Kontrazeptiven Verhalten.]
  155. Psycho-somatic aspects of contraception within the family.
  156. Psychological factors in contraceptive failure and abortion request. (Editorial)
  157. Psychological factors in contraceptive failure and abortion request. (Letter to the Editor)
  158. Psychological resistance of women to the principal female methods of contraception. Essay of clinical classification. [Resistances psychologiques des femmes aux principales methodes feminines de contraception. Essai de classification clinique.]
  159. Psychology of contraception.
  160. Psychosexual changes in contraception. [Cambios psicosexuales con la anticoncepcion.]
  161. Psychosomatic aspects of contraception.
  162. Psychosomatic problems in oral contraception: two severe cases of depression.
  163. Psychosomatic sterility and infertility and hypnotic contraception. [Sterilita e infertilita psicosomatiche e la contraccezione ipnotica.]
  164. Pulmonary scintigraphy in the initial evaluation and supervision of oral contraception. [La scintigraphie pulmonaire dans le bilan initial et dans la surveillanc e de la contraception orale.]
  165. Pyelonephritis as a side effect of hormonal contraception: an experiment al research.
  166. Quantitative determination of serum proteins in the cervical mucus after treatment with a combined contraceptive preparation. [Kolichestveno opredelyane na serumnite belt'tsi v tservikalniya mukus sled priemane na kombiniran protivozachat'chen preparat.]
  167. Questions in the commons. (Family planning)
  168. Race consciousness and fears of black genocide as barriers to family planning.
  169. Radio and television spot announcements and the 25 critical obstacles. Obstacle 10: lack of awareness of family planning services.
  170. Radio and television spot announcements and the 25 critical obstacles. Obstacle 11: failure to diffuse information about private and commercial family planning sources.
  171. Radio and television spot announcements and the 25 critical obstacles. Obstacle 12: prejudices for and against particular methods of contraception.
  172. Radio and television spot announcements and the 25 critical obstacles. Obstacle 14: contraceptive fatigue, carelessness and negligence.
  173. Radio and television spot announcements and the 25 critical obstacles. Obstacle 17: anxieties about contraceptive failure.
  174. Radio and television spot announcements and the 25 critical obstacles. Obstacle 19: neglect of environmental protection, national economic development and community welfare as motives for family planning.
  175. Radio and television spot announcements and the 25 critical obstacles. Obstacle 1: fears of permanent damage to health from prolonged use of pill, IUD, or other contraceptive.
  176. Radio and television spot announcements and the 25 critical obstacles. Obstacle 24: withholding family planning information from sexually active teenagers and other mature unmarried persons.
  177. Radio and television spot announcements and the 25 critical obstacles. Obstacle 25: underexploitation of the immediate and intermediate advantages and benefits of family planning.
  178. Radio and television spot announcements and the 25 critical obstacles. Obstacle 3: lack of leadership awareness that the masses want family planning.
  179. Radio and television spot announcements and the 25 critical obstacles. Obstacle 5: inadequate communication between husbands and wives about ideal family size, spacing, contraceptive methods, and whether to practice family planning.
  180. Radio and television spot announcements and the 25 critical obstacles. Obstacle 7: slowness to desexualize family planning and reduce shyness about family planning behavior.
  181. Radio and television spot announcements and the 25 critical obstacles. Obstacle 9: family planning rumors.
  182. Rational advice on contraception? A preliminary report. [Rationell preventivmedelsradivning? En preliminar rapport.]
  183. Reaching the forgotten: contraception for the institutionalized woman.
  184. Realistic family planning must sell new view of sexuality at local, national levels.
  185. Recent advances in intrauterine contraception.
  186. Receptivity of postpartum patients to family planning information and methods in a large metropolitan hospital (1967-1974)
  187. Recherche systematique de la blennorragie dans une consultation de planning familial. (Value of screening for gonorrhea at a family planning consultation.)
  188. Recruiting the uncommitted leader for family planning.
  189. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
  190. Reflections on the role of family planning centers and their staff. [Reflexions sur le role des centres de planification et d'education familiale et sur celui des personnels d'encadrement.]
  191. Regional Family planning education and communication workshops. Final report.
  192. Regional Workshop on Social Welfare Aspects of Family Planning, Bangkok, Thailand, December 12-21, 1974.
  193. Registry for liver tumors associated with oral contraceptives. (Letter)
  194. The relationship between first sexual intercourse and ways of handling contraception among college students.
  195. Relationship between levels of blood lipids, Vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
  196. Relationship with putative father and use of contraception in a population of black ghetto adolescent mothers.
  197. Report and recommendations: Workshop on the Role of Computers in the Development of an International Technical Information Network for Population/Family Planning.
  198. Report of a congress devoted to intrauterine contraception. [A propos d'un congres consacre a la contraception intra-uterine.]
  199. Report of a Group Meeting on the Teaching of Maternal and Child Health and Family Planning in Medical and Nursing Institutions, Alexandria, Egypt, February 19-23, 1973.
  200. Report of International Contraceptive Study Project, Geneva, September 22-23, 1975.
  201. Report of the experts meeting on the evaluation of family planning communication programmes, Davao City, Philippines, April 23-27, 1974.
  202. Report of the Inter-regional Meeting on the Training and Utilization of the Traditional Birth Attendant in Maternal and Child Health and Family Planning, Quezon City, Philippines, December 2-6, 1974.
  203. Report of the National Management Seminar on Population and Family Planning.
  204. Report of the workshop: Community Based Distribution of Contraceptives, Tokyo, September 30-October 4, 1974.
  205. Report of workshop on laws relating to paramedical role in contraception.
  206. Report of workshop on the manufacture and distribution of contraceptives.
  207. Report on the June 1974 Bangkok meeting. (Family planning; abortion)
  208. Report to the Congress. Improving federally assisted family planning programs.
  209. Reproductive motivation versus contraceptive technology: is recent American experience an exception?
  210. Research needs in contraceptive sterilization: a comment.
  211. Research on human reproduction provides new leads to male, female contraception.
  212. Resistance of doctors to contraception. [Les resistances du corps medical a la contraception.]
  213. Resistance of the press to contraception. [Resistances de la presse a la contraception.]
  214. Resistance of women to contraception. [Resistance des femmes a la contraception.]
  215. Resistance to contraception. [Resistance a la contraception.]
  216. Resistances of teenagers to contraception. [Resistances de la mineure a la contraception.]
  217. Resistances to mechanical contraceptive technique. [Resistances a la contraception mecanique.]
  218. Resources for public family planning services in Michigan, 1975-85.
  219. Response to short-duration signals, pre- and postmenses, in subjects using oral contraceptives and subjects not using oral contraceptives.
  220. Results following clinical application of various types of intrauterine contraception. [Rezultaty klinicheskogo primeneniya razlichnykh vidov vnutrimatochnoi kontratseptsii.]
  221. Results of in vitro sperm penetration tests in cervical mucus in the normal cycle and in mucus under the influence of the contraceptive pill.
  222. Results of prospective ophthalmological observations during hormonal contraception. [Ergebnisse prospektiver ophthalmologischer Beobachtungen unter hormonale r Kontrazeption.]
  223. Retinal vascular occlusion induced by oral contraceptives.
  224. Retinitis pigmentosa and birth control pills.
  225. A retrospective case-control study of diseases associated with oral contraceptive use.
  226. Reversibility of female contraception. [La reversibilite de la contraception feminine.]
  227. A review of commonly used intrauterine contraceptive devices.
  228. Smoking, oral contraceptives, and obesity: effects on white blood count.
  229. Social factors in adolescent use of contraception.
  230. Social marketing - its place in family planning programmes.
  231. The social psychology of family planning in a part-Aboriginal rural community, 1970 to 1973.
  232. Social science research on family planning in developing countries.
  233. Social security and family planning.
  234. Social work in action: an international perspective on population and family planning.
  235. Some aspects of contraception in 1975. Part 1. [Quelques aspects de la contraception en 1975. 1re partie.]
  236. Some comments on family planning programme.
  237. Some considerations of incentives and disincentives in the promotion of family planning: India's experience.
  238. Some effects of an oral contraceptive on dietary carbohydrate-lipid interrelationships in the baboon.
  239. Some estimates of contraceptive practice in the Panama Republic. [Algunas estimaciones sobre la practica anticonceptiva en la Republica de Panama.]
  240. Some findings in the Walnut Creek contraceptive drug study after 5 years . (Abstract only)
  241. Some improvement in prescribing oral contraceptives as predicted by a computer simulation.
  242. Some indices of a response reaction of the organism in intrauterine contraception. [Nekotorie pokazateli otvetnoi reaktsii organizma pri vnutrimatochnoi kontratseptsii.]
  243. Some influential attitudes about family limitation and the use of contraceptives among the professional group in Sierra Leone.
  244. Some legal problems associated with family planning. [Nektere pravni otazky spojene s planovanym rodicovstvim.]
  245. Some major issues regarding the use of computers in a population/family planning information network.
  246. Some results of an Irish family planning survey.
  247. Some social and attitudinal factors associated with contraceptive choice among low income black teen-agers after an illegitimate birth.
  248. Some thoughts on the role of organized labour in population and family planning.
  249. Sources for audio-visual materials in population education and family planning.
  250. Sources of information on population/family planning: A handbook for Asia.
  251. South Asia 1974: an overview. (Family planning programs)
  252. The spatial diffusion of birth control in Chile. (Doctoral dissertation, Pennsylvania State University, 1972)
  253. A specialised agency for a workers family planning education programme.
  254. A specific action programme for achieving optimum results for family planning in the organised sector.
  255. Speech (on Singapore family planning.)
  256. Speech by Minister for Education, at the family planning and population education seminar for teachers on Friday, 14 March 1975 at the Singapore conference hall.
  257. Speech on history of natural family planning]
  258. Speech. (Trade unions and family planning.)
  259. Speech. (Trade Unions and Family Planning.)
  260. Spontaneous pulmonary embolism during the use of an oral contraceptive. [Spontane longemobolie tijdens het gebruik van een oraal anti conceptivum.]

     

  261. Sri Lanka. (Family planning programs)
  262. Sri Lanka: the impact of allowing paramedical prescription and resupply of oral contraceptives.
  263. Staff attitudes toward a family planning service in the mental hospital.
  264. Statement for Planned Parenthood Federation of America (on IUD's)
  265. Statements by representatives of international agencies on population questions: International Planned Parenthood Federation (IPPF)
  266. States fail to assume responsibility for provision of family planning services.
  267. A statewide family planning program's effect on fertility.
  268. Statistics related to family planning in Singapore, 1966-1974.
  269. Status of research in Latin America with direct implications for family planning programs.
  270. Status of women and family planning in Yugoslavia: report submitted to the UN Seminar on Status of Women and Family Planning, Istanbul, 11-24 July, 1972.
  271. Status of women and family planning: report of the Special Rapporteur appointed by the Economic and Social Council under resolution 1326 (XLIV)
  272. Status of women and family planning: report of the special rapporteur appointed by the economic and social council under resolution 1326. (44)
  273. Status of women, family planning and population dynamics.
  274. Status of women, family planning and population dynamics: background paper submitted to the UN Symposium on Law and Population, Tunis, 17-21 June, 1974.
  275. Sterilization and family planning in Taiwan, The Republic of China.
  276. Steroid oral contraceptives and glucose regulation. [Contraceptifs oraux steroidiens et glycoregulation.]
  277. Steroidal contraceptive therapy: hepatomas and Vitamin A. (Letter to the editor)
  278. Stimulated plasma prolactin levels in women using medroxyprogesterone acetate or an intrauterine device for contraception.
  279. Stimulating demand for family planning: a proposal.
  280. Stomatological side effects of hormonal contraceptives. [Hormonalis fogamzasgatlok stomatologiai mellekhatasai.]
  281. Strategic decision-making in a social program. The case of family-planning diffusion.
  282. Strategies in communicating with workers on family planning and population issues.
  283. Strategy for family planning programmes in the industrial sector.
  284. The strategy of family planning promotion in El Salvador.
  285. Structure and decisions in American family planning program.
  286. Studies of blood glucose and plasma insulin in "normal" women using mechanical contraception for 6 months.
  287. Studies of plasma lipids during treatment with hormonal oral contraceptives. [Untersuchungen der Plasmalipide unter dem Einfluss oraler hormonaler Kon trazeptiva.]
  288. A study of abortion in 200 women in the Dominican republic: recommendations for family planning education. [Estudio del aborto en 200 mujeres en la Republica Dominicana: recomendaciones para la educacion en planificacion familiar.]
  289. A study of oral pill acceptors of the Bangladesh postpartum family planning program.
  290. A study of pills users from a family planning clinic in Bombay.
  291. A study of some behavioral problems in sequential processes of adoption in family planning.
  292. Study of the concentration of 2, 3-diphosphoglycerate -- 2,3-DPG -- in red blood cells of women during the natural menstrual cycle and the cycle during oral contraception. [Etude de la concentration intra-erythrocytaire de 2,3 diphosphoglycerate -- 2,3 DPG -- chez la femme au cours du cycle menstruel naturel et du cycle sous contraceptif oral.]
  293. A study of the effect of oral contraceptive agents on the absorption, metabolic conversion and urinary excretion of a naturally-occurring folate (citrovorum factor)
  294. A study of the effectiveness of the family planning clinics in the Philippines.
  295. A study of the effects of oral contraceptives on abnormal cervical cytology.
  296. Study of the influence of some factors on conception and fertility rates in sheep in the anestrus period. Study of the influence of some factors on contraception and fertility rates in sheep in the estrous period. [Projuchvane vlijanieto na njakoi faktori virkhu zaplodjaemostta i plodovitostta na ovtse izvinrazmnozhitelen period. Prouchvane vliianieto na niakoi faktori v'rkhu vaplodiaemostta i plodovitoftta na ovtse v ivv'nrazmnozhitelen period.]
  297. A study on delivery of family planning services to rural communities in Chiang Mai Province, Thailand by a mobile family planning unit.
  298. Study on the action of D-norgestrel as a postcoital contraceptive agent.
  299. Study on the diffusion of menstrual regulation at the family planning clinic.
  300. SubSaharan Africa 1974: an overview. (Family planning programs)
  301. Summary of the development of family planning programs in the state of California.
  302. Summary of thirteenth national survey on family planning.
  303. Summary of Twelfth National Survey on Family Planning.
  304. Supervision of a woman taking oral contraceptives. [Surveillance d'une femme sous contraception orale.]
  305. Supplementary pyroxidine given to women using oral contraceptives. [Letter]
  306. Surveillance for carcinogenesis in women using Cu-IUD for contraception.
  307. Survey of consumers' perceptions of patient package inserts for oral contraceptives. Final Report.
  308. Survey of contraception in psychiatric practice. [Enquete sur la contraception en milieu psychiatrique.]
  309. Survey of dropouts from family planning clinics--1975.
  310. Survey of European family planning organizations, January, 1975. Part 2. [Umfrage bei europaischen Familienplanungsorganisationen in Januar 1975 Teil 2.]
  311. A survey of family planning attitudes among the Islamic leadership in South Thailand.
  312. Survey of health professionals regarding family planning.
  313. A survey of the content taught in family planning in the nursing schools of France.
  314. The sweet contraceptive.
  315. Systematic colposcopy in family planning counseling. [Colposcopia sistematica en una consulta de planificacion familiar.]
  316. Systemic contraceptives and the liver. (Letter to the editor)
  317. Systemic contraceptives and the liver. (Letter to the editor)
  318. A systems approach to family planning in a North Indian state.
  319. Systems approach to the design, production and evaluation of family-planning film-clips for THA/72/PO7.
  320. Tables and figures for the impact of subsidized family planning programs on contraceptive use in low income neighborhoods of selected U.S. cities.
  321. Taiwan. (Family planning programs)
  322. Taiwan. (Family planning)
  323. Talking family planning: a fieldwork handbook.
  324. Targets, messages and media: family planning information and education strategies in Latin America.
  325. The teaching of family planning in the medical schools.
  326. The technique of vasectomy as a method of contraception. [Technique de la vasectomie comme moyen de contraception.]
  327. Teenage pregnancy: the nonuse of contraception.
  328. Teenagers, contraception, and pregnancy.
  329. Ten years experience with intrauterine contraception in Poland.
  330. Thai doing well with first contraceptives supermarket.
  331. Thailand. (Family planning programs)
  332. Thailand: estimates of the potential impact of family planning on maternal and infant mortality.
  333. Therapeutic indications for contraceptive steroids. [Therapeutische Indikationen kontrazeptiver Steroide.]
  334. Therapeutic listening: an adolescent guidance program in motivation for contraception.
  335. Thermometric methods: study of their efficacy in birth control. [Metodos termometricos: estudio de su eficacia en la regulacion de los nacimientos.]
  336. Thiamine status and oral contraceptives.
  337. Thoughts on contraception and family planning clinics.
  338. A three year follow-up report on training standardization and utilization of family planning nurse practitioners.
  339. Thromboembolic complications of oral contraceptive therapy.
  340. Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
  341. Thrombosis with low-estrogen oral contraceptives.
  342. Thrombotic complications of orally administered contraceptives. [Thrombotische Komplikationen der per os verabreichten Antikonzipienta.]
  343. Topical nonhormonal contraception. [La contraccezione locale agenica.]
  344. Toward the comprehensive planning of national family planning programmes: a review of the ESCAP target-setting project and complementary developments.
  345. Towards continued strengthening of the Planned Parenthood Federation.
  346. Towards replacement level (The Singapore National Family Planning and Population Program: 1966-1974)
  347. The traditional birth attendant in maternal and child health and family planning: a guide to her training and utilization.
  348. Traditional contraception in Africa. [La contraception traditionelle en Afrique.]
  349. Traditional contraceptive and abortive methods. [Metodos anticonceptivos y abortivos tradicionales.]
  350. Traditional midwives and family planning in Asia.
  351. Traditional midwives and family planning.
  352. Use of effective contraception and birth planning success: a multivariate analysis.
  353. Use of nurses in family planning.
  354. The use of oral contraceptive preparation at the present-day stage. [Primenie oralnikh kontraseptivov na sovremennom etape.]
  355. Use of radio in family planning, sex education and development programs. Follow-up seminar for CIACOP graduates, in cooperation with the Dominican Association for Family Welfare, Santo Domingo, Dominican Republic, 1-5 December 1975. Report by the Training Director.
  356. The use of sterile medroxyprogesterone acetate suspension as a contraceptive during a three-year period.
  357. Use-Effectiveness of contraception.
  358. The use-effectiveness of two contraceptive methods in a Navajo population: the problem of program dropouts.
  359. Using commercial resources in family planning action-oriented IEC programmes.
  360. Using service statistics for improving family planning program operations.
  361. Using the public health nurse as a family planning clinician in rural areas: a program evaluation.
  362. Uterine perforation by intra-uterine contraceptive devices and their laparoscopic removal.
  363. The uterine therapeutic system: a new approach to female contraception.
  364. Utility of a computerized family planning data processing system, Maryland, 1968-1974.
  365. The utilization of conception cohorts for the evaluation of family planning programs.
  366. Vaginal cytology due to hormonal contraceptives. [Quadri colpocitologici determinati da contraccettivi ormonali.]
  367. Vaginal cytology in oral contraceptive.
  368. The valuation of men and the principles of cost-benefit analysis of family planning services.
  369. Variations in the modulus of family planning clinics.
  370. Vascular headaches - contraindication to oral contraceptives.
  371. Vasectomy as a method of contraception. [Vasectomi som svangeskabsforebyggelse.]
  372. Vasectomy: method for male contraception. [La vasectomie: methode de contraception masculine.]
  373. Vasomotor rhinitis: a side-effect of hormonal contraception? [Vasomotorische Rhinitis Eine Nebenwirkung hormonaler Kontrazeption?]
  374. Venezuela. (Can patients e educated in a clinic about family planning?)
  375. Vietnam (South). (Family planning programs)
  376. The view from our side: sex and birth control for men.
  377. Vitamin B6 requirements of women using oral contraceptives.
  378. Vitamin E status and oral contraceptives. (Letter to the editor)
  379. Vitamins and oral contraceptive use.
  380. Vitamins and oral contraceptive use.
  381. Vitamins and oral contraceptives. (Letter to the editor)
  382. In vitro studies on cervical contraception: use of urea as a spermicidal agent.
  383. Welfare workers as family planning change agents and the perennial problem of heterophily with welfare clients.
  384. When oral contraceptives talk back.
  385. Where next? An overview of youth and family planning.
  386. Why contraceptive advice? [Varfor preventivmedelsradgivning?]
  387. Why family planning involves every GP.
  388. Why family planning is failing.
  389. Will the panther capture Jamaica's mood? (Family planning)
  390. Withdrawal of high estrogen containing oral contraceptives and the demand for medical service. [Hojostrogen p-pillers tilbagetraekning og eftersprogsel paa laegelig service.]
  391. Women in family planning.
  392. Women who need and receive family planning services: estimates at mid-decade.
  393. Working women in Singapore - some family planning and population considerations.
  394. Workshop ideas for family planning education.
  395. Workshop-conference on population, family planning, and development in Nepal, jointly sponsored by His Majesty's Government of Nepal-Family Planning/Maternal and Child Health Project, Nepal-University of California Family Planning/ Maternal and Child Health Project, Berkeley, California, August 24-29, 1975. [Proceedings]
  396. The world's laws on contraceptives.
  397. Younger women in Taiwan want smaller families, fewer sons; birth control use is found widespread.
  398. Zen and the art of planned parenthood maintenance (an inquiry into values)
  399. Influence of hormonal contraceptives on the occurrence of vaginal mycoses. [Der Einfluss von hormonalen kontrazeptiva auf das Vorkommen von Vaginalmyrosen.]
  400. The initiation of contraception.
  401. Extension of family planning service in general practice.
  402. Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragm.
  403. A research note on children viewed as contributors to marital stability: the relationship to birth control use, ideal and expected family size.
  404. Biliary excretion and hepatotoxicity of contraceptive steroids.
  405. Cost versus effectiveness of different birth control methods.
  406. Dynamics of suppression and recovery of plasma FSH, LH, Androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
  407. Family planning in the third world.
  408. Intracranial venous thrombosis complicating oral contraception.
  409. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
  410. Oral contraception and increased formation of high molecular weight derivatives of fibrinogen.
  411. Peripheral haemodynamic effects of combined oestrogen/progestogen oral contraceptives.
  412. Post coital contraception: pilot study.
  413. Progestational agents and blood coagulation: 6. Relationship of ABO blood types to changes induced by oral contraceptives.
  414. Tuboovarian abscess associated with laparoscopic tubal cauterization and the intrauterine contraceptive device.
  415. Use-effectiveness of six-month injections of DMPA as a contraceptive.
  416. Vitamin A and the teratogenic risks of oral contraceptives. [Letter]
  417. The modern condom: a quality product for effective contraception./Le preservatif moderne : un produit qualite pour une contraception efficace./O Condom moderno : um produto de qualidade para a efetiva prevencao da Gravidez./El condon moderno: un producto de calidad para efectividad anticonceptiva.
  418. Oral contraceptives - 50 million users./Les contraceptifs oraux : 50 millions d'utilisatrices./Os contraceptivos orais : 50 milhoes de usuarias./Los antieonceptivos ouales : 50 millones de consumidoras.
  419. Influence of a combined oral contraceptive upon rats fed low protein/high carbohydrate diets.
  420. Influence of contraception in some demographic changes in the community of Maribor. [Vpliv kontracepcije na nekatere demografske spremebe v obcini Maribor.]
  421. The influence of contraceptive hormones on lactation.
  422. Influence of contraceptive steroids on reproduction and post-natal development.
  423. Influence of injectable steroid contraceptives on tissue lipids of female guinea pigs.
  424. Influence of oral contraception on cytology and histology of the cervix uteri.
  425. Influence of oral contraceptives on circulating immune response: 1. Effect of combination type contraceptives.
  426. Influence of oral contraceptives on circulating immune response: 2. Effect of progestogenic and estrogenic components.
  427. Influence of oral contraceptives on parameters of body composition in young women. (Abstract only)
  428. Influence of oral contraceptives on serum zinc and copper concentrations. (Abstract only)
  429. Influence of oral contraceptives on the rat exocrine pancreas: a histologic, histochemical, and electron microscopic study.
  430. The influence of oral contraceptives on the ratio of Factor 8 activity to Factor 8 related protein.
  431. Influence of previous oral contraception and maternal oxytocin infusion on neonatal jaundice.
  432. Informal role strategies of outreach workers in family planning clinics.
  433. Information education and motivation for family planning.
  434. Information, education and family planning) [Information, education et planification familiales.]
  435. The initiation of contraception.
  436. Injectable long-acting progestogen contraception: a neglected modality.
  437. Innovation in birth control via the non-profit corporation.
  438. Insights into behavior patterns of the Filipino: their significance to family planning work.
  439. Integrated family planning: the Chilean experience.
  440. An integrated health/family planning program in Etimesgut District, Turkey.
  441. Integration of family planning with health services--a preliminary study.
  442. Inter-block variations in family planning achievements.
  443. Inter-country course in maternal-child health and family planning for nurses and nurse-midwives in the English speaking Caribbean June 4-July 20, 1974.
  444. Inter-state variation in family planning performance in India.
  445. Interaction of contraceptive steroids with metabolic functions of Vitamin B6. (Abstract only)
  446. Interference by oral contraceptives and antiepileptic drugs on plasma parameters in humans. [Interference des contraceptifs oraux et des anti-epileptiques sur les parametres plasmatiques chez l'homme.]
  447. Evaluation of family planning experimental information and education programmes at Maternidad Concepcion Palacios (MCP), Caracas, Venezuela. (Doctoral dissertation, Cornell University, June 1974.)
  448. The evaluation of Ovulen 50 mcg. as oral contraceptive.
  449. An evaluation of the clinical program of the family planning associations, Malaysia.
  450. Evaluation of the effectiveness of illustrated print media (nonverbal) on family planning attitudes among Colombians.
  451. Evaluation of the Gravigard intrauterine copper contraceptive device.
  452. Evaluation of the performance of the auxiliaries trained at the Regional Family Planning Training Centers: diagnostic study.
  453. An evaluation of the Tunisian National Family Planning Programme.
  454. The evolution of a contraception program.
  455. Evolution of obstetrics, gynaecology and family planning in India.
  456. An example of a presentation to a university administration recommending gynecological and contraceptive services.
  457. An example of an approach to administration and evaluation of non-clinical distribution of oral contraceptives.
  458. The experience of running a family planning clinic.
  459. Experience with a combined multiload contraceptive intrauterine device. (Abstract only)
  460. Experience with Ciclo-Provera, a monthly parenteral contraceptive. [Experiencia con Ciclo-Provera, anticonceptivo mensual parenteral.]
  461. The experience with Dalkon shield in UCLA family planning clinic.
  462. Experience with Depo-Provera as an injectable contraceptive.
  463. Experience with intrauterine contraceptive device at a local Health Authority Clinic.
  464. Experience with lynestrenol. An oral contraceptive used daily in low doses. Preliminary report. [Experiencia con linestrenol. Un anticonceptivo de consumo diario oral a dosis baja. Comunicacion preliminar.]
  465. Experience with the 25-S double coil intrauterine contraceptive device. (A preliminary report)
  466. Experience with the ABCD contraceptive.
  467. Experience with the Dalkon shield as a contraceptive device.
  468. Experience with three different models of the copper T intrauterine contraceptive device in nulliparous women.
  469. Experiences in the development of a hospital family planning service.
  470. Experimental and clinical studies on estrogens, progestins, oral contraceptives and benign breast lesions.
  471. Experimental and clinical studies on relationship of estrogens and oral contraceptives to breast cancer.
  472. Expert meeting between Family Planning Administrators and Commercial Marketing Executives: resume of discussions.
  473. The experts evaluate secondary methods of contraception.

     

  474. Fact book on population and family planning.
  475. Factors associated with knowledge and practice of family planning.
  476. Factors associated with short-term oral contraceptive discontinuation.
  477. Progress towards an injectable contraceptive.
  478. Project in family planning communication for rural young married couples. Volume 2: family planning film study. (Report of phase 1.)
  479. Project in family planning communication for rural young married couples:
  480. A project of design of three educational meetings for family planning using the reflexive method. [Proyecto de disegno de tres riuniones educativas en planificacion familiar con utilizacion del metodo reflexivo.]
  481. Projected survey of knowledge, research and funding in reproductive Biology and contraceptive development.
  482. A proposal to improve the production facilities of family planning information-communication-education units. Operation Slingshot: a modest solution to a giant communication problem.
  483. The prospect from the viewpoint of family planning programs.
  484. Prospects of contraception. [Perspectives de la contraception.]
  485. Provisional data from the National Reporting System for Family Planning Services April 1974-June 1974.
  486. Provisional data from the National Reporting System for family planning services, January 1973-December 1973: United States, states, and territories.
  487. Provisional data from the National Reporting System for Family Planning Services: July 1974 - September 1974.
  488. Provisional data from the National Reporting System for Family Planning.
  489. Psychocultural aspects of contraceptive behavior in Jamaica.
  490. Psychological effects of pregnancy and contraception.
  491. Psychological research in family planning: a view from Asia.
  492. Psychological research on family size and family planning in the United States.
  493. Psychology and contraception. [Psychologie et contraception.]
  494. Psychology of family planning with particular reference to natural family planning.
  495. Psychosexual aspects of oral contraceptives. [Aspectos psicossexuais da contracepcao oral.]
  496. Psychosocial aspects of contraception. [Psychosoziale Aspekte der Kontrazeption.]
  497. Psychosocial research on family planning in Europe.
  498. Psychosomatic aspects of oral contraception. [Les aspects psychosomatiques de la contraception orale.]
  499. Psychosomatic complaints as related to desire of pregnancy, contraceptive practice and frequency of intercourse.
  500. Public Health legislation and family planning.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.